Published in Clin Sci (Lond) on January 01, 2012
Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol (2013) 1.05
miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia. Am J Pathol (2013) 0.98
Differentially expressed genes in the pre-eclamptic placenta: a systematic review and meta-analysis. PLoS One (2013) 0.97
Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice. Ultrasound Obstet Gynecol (2015) 0.88
miR455 is linked to hypoxia signaling and is deregulated in preeclampsia. Cell Death Dis (2014) 0.87
Preeclampsia: a bioinformatics approach through protein-protein interaction networks analysis. BMC Syst Biol (2012) 0.83
Angiogenesis in the placenta: the role of reactive oxygen species signaling. Biomed Res Int (2015) 0.82
In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy. PLoS One (2014) 0.80
Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia. J Biomed Sci (2014) 0.80
Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa. J Perinat Med (2013) 0.80
Abnormal uterine artery remodelling in the stroke prone spontaneously hypertensive rat. Placenta (2015) 0.79
Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice. PLoS One (2015) 0.78
Serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patients. ISRN Obstet Gynecol (2013) 0.78
Placental growth factor influences maternal cardiovascular adaptation to pregnancy in mice. Biol Reprod (2014) 0.77
Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia. Int J Mol Sci (2015) 0.75
Microvascular function in pre-eclampsia is influenced by insulin resistance and an imbalance of angiogenic mediators. Physiol Rep (2017) 0.75
Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration. Int J Mol Sci (2015) 0.75
Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study. Arthritis Res Ther (2015) 0.75
2-methoxyestradiol plasma levels are associated with clinical severity indices and biomarkers of preeclampsia. Reprod Sci (2014) 0.75
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med (2005) 4.84
Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation (2011) 3.33
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med (2016) 2.99
Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol (2002) 2.50
Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage. Circ Res (2007) 2.25
The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens (2010) 2.23
Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension (2007) 2.17
The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome. J Perinat Med (2013) 2.06
Prorenin receptor is essential for podocyte autophagy and survival. J Am Soc Nephrol (2011) 2.04
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension (2009) 2.00
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol (2009) 1.92
Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. Hypertension (2005) 1.89
Dysfunction of dysferlin-deficient hearts. J Mol Med (Berl) (2007) 1.89
Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids. J Biol Chem (2010) 1.83
Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation (2009) 1.77
Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension (2008) 1.65
Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension (2007) 1.56
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol (2011) 1.50
Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension (2005) 1.48
Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension (2008) 1.48
Vitronectin concentrations predict risk in patients undergoing coronary stenting. Circ Cardiovasc Interv (2008) 1.44
Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension (2004) 1.44
Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension (2012) 1.39
Effect of terminated fetal circulation on maternal angiogenic factors in severe early preeclampsia. Hypertens Pregnancy (2012) 1.39
Natriuretic peptide system in fetal heart and circulation. J Hypertens (2002) 1.38
Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension (2011) 1.34
Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation (2004) 1.32
High salt reduces the activation of IL-4- and IL-13-stimulated macrophages. J Clin Invest (2015) 1.30
Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. Am J Hypertens (2011) 1.24
Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension (2011) 1.24
Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. Circulation (2005) 1.23
New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension (2013) 1.20
The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol (2008) 1.19
Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension. PLoS One (2008) 1.19
IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol (2012) 1.18
New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol (2004) 1.17
Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am J Physiol Regul Integr Comp Physiol (2012) 1.17
Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension (2008) 1.16
A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia. J Clin Endocrinol Metab (2009) 1.16
A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury. Am J Pathol (2004) 1.15
Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol (2002) 1.15
Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf) (2012) 1.14
Angiotensin II-induced sudden arrhythmic death and electrical remodeling. Am J Physiol Heart Circ Physiol (2007) 1.13
Complement activation in angiotensin II-induced organ damage. Circ Res (2005) 1.13
Uterine vascular function in a transgenic preeclampsia rat model. Hypertension (2008) 1.12
Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension (2010) 1.11
Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension (2011) 1.11
Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction. Gend Med (2011) 1.07
Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension (2009) 1.05
Immune mechanisms in angiotensin II-induced target-organ damage. Ann Med (2012) 1.01
Angiogenesis factors and preeclampsia. Nat Med (2008) 1.01
Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats. BMC Cardiovasc Disord (2002) 1.00
Heparin strongly induces soluble fms-like tyrosine kinase 1 release in vivo and in vitro--brief report. Arterioscler Thromb Vasc Biol (2011) 1.00
Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension. Hypertension (2007) 0.99
Increased angiotensin II in the mesometrial triangle of a transgenic rat model of preeclampsia. Hypertension (2009) 0.99
Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. Eur J Heart Fail (2007) 0.99
Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med (2006) 0.98
Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension (2013) 0.98
Fibrosis rather than blood pressure determines cardiac BNP expression in mice. Regul Pept (2003) 0.97
AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia. J Mol Med (Berl) (2008) 0.97
p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension (2007) 0.97
Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism (2009) 0.96
Umbilical cord hypercoiling and thinning: a rare cause of intrauterine death in the second trimester of pregnancy. Pediatr Dev Pathol (2006) 0.96
Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation. Int J Interferon Cytokine Mediat Res (2011) 0.96
Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy. Hypertension (2013) 0.95
Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy. Hypertension (2010) 0.95
Effects of circulating and local uteroplacental angiotensin II in rat pregnancy. Hypertension (2010) 0.94
CD19+CD5+ cells as indicators of preeclampsia. Hypertension (2012) 0.93
The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem (2012) 0.92
The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur J Obstet Gynecol Reprod Biol (2010) 0.91
Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf) (2008) 0.91
Robust fetal ECG extraction and detection from abdominal leads. Physiol Meas (2014) 0.91
Lipoic acid supplementation prevents angiotensin II-induced renal injury. Kidney Int (2003) 0.90
Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia. Circulation (2012) 0.90
Single nucleotide polymorphisms in G protein signaling pathway genes in preeclampsia. Hypertension (2013) 0.89
Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth (2014) 0.89
Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr (2010) 0.88
Cardiac gene expression profile in rats with terminal heart failure and cachexia. Physiol Genomics (2004) 0.88
Secretory products from human adipocytes impair endothelial function via nuclear factor kappaB. Atherosclerosis (2007) 0.87
Aliskiren--mode of action and preclinical data. J Mol Med (Berl) (2008) 0.87
Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension. J Renin Angiotensin Aldosterone Syst (2008) 0.86
Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol (2008) 0.86
Secretory products from human adipocytes stimulate proinflammatory cytokine secretion from human endothelial cells. J Cell Biochem (2009) 0.86
Alpha1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats. PLoS One (2010) 0.86
Seeking the mechanism(s) of action for corticosteroids in HELLP syndrome: SMASH study. Am J Obstet Gynecol (2013) 0.85
Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension. Circulation (2008) 0.85
Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus. Hypertension (2009) 0.84
Amyloid-β peptides activate α1-adrenergic cardiovascular receptors. Hypertension (2013) 0.84
Short-term couplings of the cardiovascular system in pregnant women suffering from pre-eclampsia. Philos Trans A Math Phys Eng Sci (2010) 0.84
Classification of cardiovascular time series based on different coupling structures using recurrence networks analysis. Philos Trans A Math Phys Eng Sci (2013) 0.84
Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors. Obstet Gynecol (2007) 0.83
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia--the PreOS study protocol. Hypertens Pregnancy (2015) 0.83
Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide. Biol Chem (2004) 0.83
Agonist autoantibodies against the angiotensin AT1 receptor in renal and hypertensive disorders. Curr Hypertens Rep (2007) 0.83
Soluble fms-like tyrosine kinase 1. N Engl J Med (2004) 0.82
Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage. Kidney Int (2005) 0.82
Effect of steroids on angiogenic factors in pregnant women with HELLP syndrome. J Perinat Med (2011) 0.82
Knock-down of endothelial connexins impairs angiogenesis. Pharmacol Res (2011) 0.82
Trophoblasts reduce the vascular smooth muscle cell proatherogenic response. Hypertension (2008) 0.82
IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia. Hypertens Pregnancy (2015) 0.81